In the current study, we demonstrated that mice with tissue-derived CCL5 deletion were protected against HFD-induced adipose tissue inflammation and insulin resistance, which was not observed in those with BM-derived CCL5 deletion. The gene discussed is CCL5; the disease is Insulin resistance.